Transcripts
Ligand Pharmaceuticals (LGND) earnings call transcripts
Earnings call transcripts for Ligand Pharmaceuticals Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the quarter as validation of its royalty-aggregation strategy, with Zoma adding scale and duration while keeping underwriting discipline unchanged.
Aug 06, 2026Confident0.78